Literature DB >> 17787016

Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3.

Allison D Ebert1, Hoo Jae Hann, Martha C Bohn.   

Abstract

6-Hydroxydopamine (6-OHDA), a neurotoxin that causes the death of dopamine (DA) neurons, is commonly used to produce experimental models of Parkinson's disease (PD) in rodents. In the rat model of PD first described by Sauer and Oertel, DA neurons progressively die over several weeks following a striatal injection of 6-OHDA. It is generally assumed that DA neurons die through apoptosis after exposure to 6-OHDA, but data supporting activation of a caspase enzymatic cascade are lacking. In this study, we sought to determine if caspases involved in the intrinsic apoptotic cascade play a role in the initial stages of 6-OHDA-induced death of DA neurons in the progressively lesioned rat model of PD. We found that injection of 6-OHDA into adult rat striatum did not activate caspase-9 or caspase-3 or increase levels of caspase-dependent cleavage products in the substantia nigra at various survival times up to 7 days after the lesion, even though this paradigm produced DA neuronal loss. These data suggest that in the adult rat brain DA neurons whose terminals are challenged with 6-OHDA do not die through a classical caspase-dependent apoptotic mechanism. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17787016     DOI: 10.1002/jnr.21480

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

1.  Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.

Authors:  Negin Nouraei; Lauren Zarger; Justin N Weilnau; Jimin Han; Daniel M Mason; Rehana K Leak
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-12       Impact factor: 4.219

2.  Non-Apoptotic Caspase-3 Activation Mediates Early Synaptic Dysfunction of Indirect Pathway Neurons in the Parkinsonian Striatum.

Authors:  Tim Fieblinger; Chang Li; Elena Espa; M Angela Cenci
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

3.  ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease.

Authors:  Valentín Cóppola-Segovia; Clarissa Cavarsan; Flavia G Maia; Anete C Ferraz; Lia S Nakao; Marcelo Ms Lima; Silvio M Zanata
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

4.  Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases.

Authors:  Tae Woo Kim; Younghye Moon; Kyungjin Kim; Jeong Eun Lee; Hyun Chul Koh; Im Joo Rhyu; Hyun Kim; Woong Sun
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

5.  Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.

Authors:  Patrick M Flood; Li Qian; Lynda J Peterson; Feng Zhang; Jing-Shan Shi; Hui-Ming Gao; Jau-Shyong Hong
Journal:  Parkinsons Dis       Date:  2011-03-30

6.  Oxidative stress and microglial cells in Parkinson's disease.

Authors:  Lynda J Peterson; Patrick M Flood
Journal:  Mediators Inflamm       Date:  2012-03-22       Impact factor: 4.711

7.  Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease by inhibiting SP1.

Authors:  Li-Jun Cai; Li Tu; Tian Li; Xiu-Lin Yang; Yi-Pin Ren; Ran Gu; Qian Zhang; Huan Yao; Xiang Qu; Qian Wang; Jin-Yong Tian
Journal:  Aging (Albany NY)       Date:  2020-01-11       Impact factor: 5.682

8.  Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson's Disease in Rats.

Authors:  Prafulla Chandra Tiwari; Manju J Chaudhary; Rishi Pal; Shipra Kartik; Rajendra Nath
Journal:  Ann Neurosci       Date:  2021-11-02

9.  Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine.

Authors:  Daniel Hernandez-Baltazar; Maria E Mendoza-Garrido; Daniel Martinez-Fong
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.